What we do
Our approach
Pipeline
About us
News & events
News
Events
Investors
Careers
What we do
Our approach
Pipeline
About us
News & events
News
Events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Archived transactions
Careers
Back
Back
Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia (AML)
8:00:00 AM
Keep reading
Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23
Read